If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Omar Ali El-Agnaf is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles
Synucleins Medicine & Life Sciences
Parkinson Disease Medicine & Life Sciences
Amyloid Medicine & Life Sciences
alpha-Synuclein Medicine & Life Sciences
Alzheimer Disease Medicine & Life Sciences
Cerebrospinal Fluid Medicine & Life Sciences
Neurodegenerative Diseases Medicine & Life Sciences
Peptides Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1994 2019

Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuospatial memory alteration

Durante, V., de Iure, A., Loffredo, V., Vaikath, N., De Risi, M., Paciotti, S., Quiroga-Varela, A., Chiasserini, D., Mellone, M., Mazzocchetti, P., Calabrese, V., Campanelli, F., Mechelli, A., Di Filippo, M., Ghiglieri, V., Picconi, B., Ali El-Agnaf, O., De Leonibus, E., Gardoni, F., Tozzi, A. & 1 others, Calabresi, P., 1 May 2019, In : Brain : a journal of neurology. 142, 5, p. 1365-1385 21 p.

Research output: Contribution to journalArticle

Synucleins
Corpus Striatum
alpha-Synuclein
Parkinson Disease
Long-Term Potentiation
3 Citations (Scopus)

Antibodies against alpha-synuclein: tools and therapies

Vaikath, N., Hmila, I., Gupta, V., Erskine, D., Ingelsson, M. & Ali El-Agnaf, O., 1 Jan 2019, In : Journal of Neurochemistry.

Research output: Contribution to journalReview article

Open Access
alpha-Synuclein
Antibodies
Lewy Bodies
Inclusion Bodies
Pathology

Correlated levels of cerebrospinal fluid pathogenic proteins in drug-naïve Parkinson's disease

Murakami, H., Tokuda, T., Ali El-Agnaf, O., Ohmichi, T., Miki, A., Ohashi, H., Owan, Y., Saito, Y., Yano, S., Tsukie, T., Ikeuchi, T. & Ono, K., 4 Jun 2019, In : BMC Neurology. 19, 1, 113.

Research output: Contribution to journalArticle

Open Access
Cerebrospinal Fluid Proteins
Parkinson Disease
Cerebrospinal Fluid
Amyloid
Pharmaceutical Preparations
15 Citations (Scopus)

CSF and blood biomarkers for Parkinson's disease

Parnetti, L., Gaetani, L., Eusebi, P., Paciotti, S., Hansson, O., Ali El-Agnaf, O., Mollenhauer, B., Blennow, K. & Calabresi, P., 1 Jun 2019, In : The Lancet Neurology. 18, 6, p. 573-586 14 p.

Research output: Contribution to journalReview article

Synucleins
Parkinson Disease
Biomarkers
Intermediate Filaments
Parkinsonian Disorders
1 Citation (Scopus)

Dihydromyricetin and Salvianolic acid B inhibit alpha-synuclein aggregation and enhance chaperone-mediated autophagy

Wu, J. Z., Ardah, M., Haikal, C., Svanbergsson, A., Diepenbroek, M., Vaikath, N., Li, W., Wang, Z. Y., Outeiro, T. F., Ali El-Agnaf, O. & Li, J. Y., 15 Jun 2019, In : Translational Neurodegeneration. 8, 1, 18.

Research output: Contribution to journalArticle

Open Access
Synucleins
alpha-Synuclein
Autophagy
Parkinson Disease
salvianolic acid B